MedPath

Prediction Of artificial reproductive technology success rate

Not Applicable
Conditions
Health Condition 1: 1- Obstetrics
Registration Number
CTRI/2021/05/033676
Lead Sponsor
Gunasheela Surgical and Maternity Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women who had undergone IVF (In vitro fertilization) /ICSI (Intracytoplasmic sperm injection)

Exclusion Criteria

1.Donor oocyte cycles

2.Donor embryo cycles

3.IVM (In vitro maturation) cycles

4.Age >40 years

5.PGS/PGD (Preimplantation genetic screening/diagnosis) cycle

6.Embryo pooling cycles

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cumulative live birth rate per oocyte retrieval, stratified according to the number of mature oocytes in younger (less than 35 years) and older women (more than 35 years)Timepoint: IVF outcome is measured at 4 weeks after the embryo transfer whether there is a clinical pregnancy or not. <br/ ><br> <br/ ><br>Pregnancy outcome is assessed as, whether they have crossed 6 months.
Secondary Outcome Measures
NameTimeMethod
Optimal number of oocytes for a successful live birth in younger (less than 35 years) and older women (more than 35 yearsTimepoint: Not applicable
© Copyright 2025. All Rights Reserved by MedPath